FDA Inspection 1289802 — Changzhou Qianhong Biopharma Co., Ltd.
The FDA completed an inspection of Changzhou Qianhong Biopharma Co., Ltd. on May 10, 2023 in Changzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 10, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Changzhou (China)
Additional details
Mutual Recognition Agreement (MRA)